In the press
David Fyfield has written for Life Sciences Intellectual Property Review on the Supreme Court's ruling in Regeneron Pharmaceuticals Inc v Kymab Ltd. Read more below (subscription required).
How patents for transgenic mice got caught in a sufficiency trap
City AM quotes Charlotte Duly on Tesco’s Clubcard rebrand after losing battle with Lidl
Charlotte Duly
In the Press
Michael Powner writes for Raconteur on AI and automating back-office roles
Michael Powner
In the Press
Thomas Snider, Reem Faqihi and Dalal Alhouti discuss the impact of technology on the arbitration landscape for Legal Community MENA
Thomas R. Snider
In the Press
Charles Russell Speechlys grows its rankings in The Legal 500 EMEA directory
Frédéric Jeannin
News
Forbes quotes Gareth Mills on the US government’s antitrust lawsuit against Apple
Gareth Mills
In the Press
The Financial Times quotes Nicola Thorpe on the importance of improving digital hygiene in the fight against cyber crime
Nicola Thorpe
In the Press
Thomas Snider, Patrick Gearon and Dalal Alhouti discuss the impact of AI on international arbitration for Legal Community MENA
Thomas R. Snider
In the Press
World Intellectual Property Review quotes Charlotte Duly on Tesco’s trademark row with Lidl over its Clubcard logo
Charlotte Duly
In the Press
A Modern Marriage: How AI Powered By Blockchain Could Protect IP Rights
Shennind Awat-Ranai
Insights
Thomas Snider and Dalal Alhouti write for New Law Journal on international arbitration trends
Thomas R. Snider
In the Press
UK Government AI Regulation Response & Roadmap – Is the Government behind the wheel?
Mark Bailey
Insights
Charles Russell Speechlys advises the management sellers of Membr on its sale to Xplor Technologies
Andrew Clarke
News
Fortune quotes Richard Davies on sponsorship deals and the strength of brand/supporter loyalty in football
Richard Davies
In the Press